The Board of Directors of Zensar Technologies approved the companys financial results for the quarter and half year ended September 30, 2023, reconstituted the Nomination and Remuneration Committee, and made amendments to the Policy on Determination of Materiality of Events. Additionally, Zensar Technologies announced the pursuit of Healthcare and Life Sciences as a separate vertical.